Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients

NCT01852045 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
114
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan